ERBB2 and cancer: Out of these patients, 61 patients with preoperative systemic therapy, two patients who underwent incisional biopsy at other hospitals, three patients without evaluable invasive lesion in the surgical specimen, and three and four patients with ER− and HER2− cancer, respectively, on pathological reassessment were excluded.